Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
35
TGA:35
Drug Approvals
AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe (444942)
- Product Name
- AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled syringe
- Approval Date
- May 30, 2025
TGA
AVTOZMA tocilizumab (rch) 80 mg/4 mL injection concentrated vial (444940)
- Product Name
- AVTOZMA tocilizumab (rch) 80 mg/4 mL injection concentrated vial
- Approval Date
- May 30, 2025
TGA
AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial (444943)
- Product Name
- AVTOZMA tocilizumab (rch) 400 mg/20 mL injection concentrated vial
- Approval Date
- May 30, 2025
TGA
AVTOZMA tocilizumab (rch) 200 mg/10 mL injection concentrated vial (444939)
- Product Name
- AVTOZMA tocilizumab (rch) 200 mg/10 mL injection concentrated vial
- Approval Date
- May 30, 2025
TGA
AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector (444941)
- Product Name
- AVTOZMA tocilizumab (rch) 162 mg/0.9 mL solution for injection pre-filled pen, AVTPen Autoinjector
- Approval Date
- May 30, 2025
TGA
STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe (442991)
- Product Name
- STOBOCLO denosumab (rch) 60 mg/mL solution for injection pre-filled syringe
- Approval Date
- Apr 4, 2025
TGA
OSENVELT denosumab (rch) 70 mg/mL solution for injection vial (442990)
- Product Name
- OSENVELT denosumab (rch) 70 mg/mL solution for injection vial
- Approval Date
- Apr 4, 2025
TGA
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle (431932)
- Product Name
- EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection vial with needle
- Approval Date
- Mar 31, 2025
TGA
EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe (431931)
- Product Name
- EYDENZELT aflibercept (rch) 40 mg/mL solution for intravitreal injection pre-filled syringe
- Approval Date
- Mar 31, 2025
TGA
OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard (427223)
- Product Name
- OMLYCLO omalizumab (rch) 75 mg/0.5 mL solution for injection in a pre-filled syringe with needle guard
- Approval Date
- Nov 26, 2024
TGA
- Prev
- 1
- 2
- 3
- 4
- Next
Clinical Trials
No trials found
News
No news found